RENAISSANCE TECHNOLOGIES LLC
Top Portfolio Positions
2,857 positions ·
$61,930,567,297 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
1,787,019 | $1,059,666,526 | 1.71% | |
| PLTR |
Palantir Technologies Inc.
Technology
|
6,985,926 | $1,021,901,255 | 1.65% | |
| AAPL |
Apple Inc.
Technology
|
3,075,638 | $780,566,168 | 1.26% | |
| KGC |
Kinross Gold Corp
Basic Materials
|
25,546,413 | $779,676,524 | 1.26% | |
| MU |
Micron Technology Inc
Technology
|
2,162,986 | $730,743,190 | 1.18% | |
| VRSN |
Verisign Inc/Ca
Technology
|
2,818,151 | $699,915,982 | 1.13% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
13,726,993 | $588,750,729 | 0.95% | |
| FNV |
FRANCO NEVADA Corp
Basic Materials
|
2,218,918 | $548,183,691 | 0.89% | |
| SNDK |
Sandisk Corp
Technology
|
799,568 | $507,997,533 | 0.82% | |
| NVDA |
Nvidia Corp
Technology
|
2,526,948 | $440,699,731 | 0.71% |
Portfolio Trend
Holdings in INVZ
Shares Held
Position Value (USD)
12 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,947,529 | 3,076,666 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,645,141 | 1,928,653 | Shares | Sole | 2026-02-12 | |
| 2025-03-31 | $208,509 | 319,800 | Shares | Sole | 2025-05-14 | |
| 2024-06-30 | $286,749 | 308,997 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $477,567 | 353,754 | Shares | Sole | 2024-05-13 | |
| 2023-03-31 | $2,884,700 | 824,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,605,798 | 408,600 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,928,742 | 370,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,390,032 | 354,600 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $981,020 | 271,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,051,172 | 165,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $161,280 | 28,000 | Shares | Sole | 2021-11-12 | |
| No 13F history on record for this holder in this stock. | ||||||